CN102667485B - 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质 - Google Patents

抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质 Download PDF

Info

Publication number
CN102667485B
CN102667485B CN201080046087.6A CN201080046087A CN102667485B CN 102667485 B CN102667485 B CN 102667485B CN 201080046087 A CN201080046087 A CN 201080046087A CN 102667485 B CN102667485 B CN 102667485B
Authority
CN
China
Prior art keywords
acid
depression
blood
patients
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080046087.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN102667485A (zh
Inventor
川村则行
篠田幸作
大桥由明
石川贵正
佐藤基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Metabolome Technologies Inc
Original Assignee
Human Metabolome Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Metabolome Technologies Inc filed Critical Human Metabolome Technologies Inc
Priority to CN201510161121.9A priority Critical patent/CN104777314B/zh
Publication of CN102667485A publication Critical patent/CN102667485A/zh
Application granted granted Critical
Publication of CN102667485B publication Critical patent/CN102667485B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/304—Mood disorders, e.g. bipolar, depression
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y10T436/163333—Organic [e.g., chemical warfare agents, insecticides, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201080046087.6A 2009-08-12 2010-08-12 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质 Active CN102667485B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510161121.9A CN104777314B (zh) 2009-08-12 2010-08-12 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2009187521 2009-08-12
JP2009-187521 2009-08-12
JP2009-291029 2009-12-22
JP2009291029 2009-12-22
PCT/JP2010/063713 WO2011019072A1 (ja) 2009-08-12 2010-08-12 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510161121.9A Division CN104777314B (zh) 2009-08-12 2010-08-12 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质

Publications (2)

Publication Number Publication Date
CN102667485A CN102667485A (zh) 2012-09-12
CN102667485B true CN102667485B (zh) 2015-04-22

Family

ID=43586246

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201080046087.6A Active CN102667485B (zh) 2009-08-12 2010-08-12 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质
CN201510161121.9A Expired - Fee Related CN104777314B (zh) 2009-08-12 2010-08-12 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510161121.9A Expired - Fee Related CN104777314B (zh) 2009-08-12 2010-08-12 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质

Country Status (6)

Country Link
US (2) US8951739B2 (https=)
EP (1) EP2466312B1 (https=)
JP (3) JPWO2011019072A1 (https=)
CN (2) CN102667485B (https=)
DK (1) DK2466312T3 (https=)
WO (1) WO2011019072A1 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5731860B2 (ja) * 2011-03-11 2015-06-10 テルモ株式会社 腹膜組織の傷害検出方法
WO2013069645A1 (ja) 2011-11-10 2013-05-16 ヒューマン・メタボローム・テクノロジーズ株式会社 エタノールアミンリン酸の測定方法
EP4385563A3 (en) 2013-01-22 2024-08-21 Vistagen Therapeutics, Inc. Dosage forms and therapeutic uses l-4-chlorokynurenine
JP6211283B2 (ja) * 2013-03-29 2017-10-11 ヒューマン・メタボローム・テクノロジーズ株式会社 脳症の検出方法
CN103630678A (zh) * 2013-03-29 2014-03-12 中国科学院城市环境研究所 男性不育的生物标志物及其应用
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
CN105431853B (zh) * 2013-05-23 2018-12-28 艾弗诺泰普有限责任公司 表型整合的社会研究数据库和方法
US20150056605A1 (en) * 2013-08-21 2015-02-26 Purdue Research Foundation Identification of blood based metabolite biomarkers of pancreatic cancer
CN103529159B (zh) * 2013-10-18 2015-05-13 哈尔滨医科大学 一种血液非靶标代谢组学研究样品的前处理方法
KR102118780B1 (ko) * 2014-09-26 2020-06-03 휴먼 메타볼롬 테크놀로지스 가부시키가이샤 우울증 치료약의 선택지를 예측하는 방법
KR101604074B1 (ko) * 2015-05-14 2016-03-17 한국과학기술원 대사체 프로파일링을 이용한 정신질환의 진단 또는 진행성 예측 방법 및 바이오마커
CN105177117A (zh) * 2015-07-03 2015-12-23 张理义 重症抑郁障碍生物标记物、筛选方法及试剂盒
CN104991010B (zh) * 2015-07-29 2017-10-13 中国药科大学 一种区分乳腺癌亚型生物标志物的组合物
EP3376229A4 (en) * 2015-11-12 2019-08-28 Kyushu University National University Corporation BIOMARKERS FOR THE DIAGNOSIS OF DEPRESSIONS AND THE USE OF THE BIOMARKER
CN105486778B (zh) * 2016-01-25 2017-11-03 齐炼文 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物
CN105445408B (zh) * 2016-01-25 2018-06-12 齐炼文 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物
EP3465202B1 (en) * 2016-06-02 2023-07-05 Metabolon, Inc. Mass spectrometry method for detection and quantitation of metabolites
AU2017325986B2 (en) * 2016-09-16 2023-12-14 Takeda Pharmaceutical Company Limited Metabolite biomarkers for diseases associated with the contact activation system
WO2018117064A1 (ja) * 2016-12-21 2018-06-28 国立大学法人徳島大学 うつ状態を呈する疾患を検査する方法
US11869633B2 (en) * 2017-12-15 2024-01-09 The Board Of Trustees Of The University Of Illinois Analytics and machine learning framework for actionable intelligence from clinical and omics data
CN111727038B (zh) * 2018-01-17 2025-05-13 南安普顿大学 肌肉减少症和nad缺乏的风险预测及分级方法
AU2019338183A1 (en) * 2018-09-11 2021-03-11 Metabolon, Inc. Mass spectrometry assay method for detection and quantitation of microbiota-related metabolites
JPWO2020122231A1 (ja) 2018-12-13 2021-10-21 キッコーマン株式会社 エタノールアミンリン酸の定量方法、定量用のオキシドレダクターゼ、定量用組成物、定量用キット及び定量用センサー
WO2020185580A1 (en) * 2019-03-13 2020-09-17 Duke University Methods and compositions for diagnosing depression
CN110286191A (zh) * 2019-06-27 2019-09-27 山西大学 一种生物样品中代谢标志物检测方法及应用
JP7607036B2 (ja) * 2019-10-11 2024-12-26 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 気分障害の改善のためのバイオマーカーとしての２－メチルブチレート
GB201916185D0 (en) * 2019-11-07 2019-12-25 Randox Laboratories Ltd Biomarker of drug-induced cellular toxicity and depression
IL298911A (en) * 2020-06-15 2023-02-01 Univ Basel Predicting response to MDMA
JPWO2021256503A1 (https=) 2020-06-17 2021-12-23
CN111693624B (zh) * 2020-06-22 2021-07-09 南京市中医院 一种与儿童多发性抽动症诊断相关的血浆代谢标志物在制备儿童多发性抽动症诊断试剂盒中的应用
CN112630311B (zh) * 2020-07-09 2023-07-18 深圳云合医药科技合伙企业(有限合伙) 用于检测情感障碍的代谢标记物和试剂盒及使用方法
US20240012008A1 (en) * 2020-10-30 2024-01-11 The Regents Of The University Of California Compositions and methods for diagnosing and treating patients with a history of early life adversity
CN114544826B (zh) * 2020-11-24 2023-12-08 重庆医科大学 检测血浆中组氨酸的试剂在制备抑郁症检测试剂盒中的用途
CN114624345B (zh) * 2020-12-10 2023-06-06 中国科学院大连化学物理研究所 一种联合生物标志物及其应用
US11854684B2 (en) * 2020-12-29 2023-12-26 Kpn Innovations, Llc. Methods and systems for nourishment refinement using psychiatric markers
US20250121014A1 (en) * 2021-09-17 2025-04-17 Societe Des Produits Nestle S.A. Method for detecting and/or quantifying mood disorder and/or improvements of the mood disorder status using butyrate as biomarker and improved methods and compositions thereof
EP4409295A1 (en) * 2021-09-28 2024-08-07 Société des Produits Nestlé S.A. Method for detecting and/or quantifying mood disorder and/or improvements of the mood disorder status using trigonelline as biomarker and improved methods and compositions thereof
US12100484B2 (en) 2021-11-01 2024-09-24 Matterworks Inc Methods and compositions for analyte quantification
US11754536B2 (en) 2021-11-01 2023-09-12 Matterworks Inc Methods and compositions for analyte quantification
JP7819901B2 (ja) * 2021-11-04 2026-02-25 国立大学法人九州大学 ひきこもりのバイオマーカー、ひきこもり識別支援方法
CN114176581A (zh) * 2021-12-06 2022-03-15 重庆邮电大学 基于体液中l-酪氨酸含量的抑郁情绪检测装置
CN116429952B (zh) * 2023-03-27 2024-02-02 深圳市第二人民医院(深圳市转化医学研究院) 一种抑郁症标志物及其在抑郁症诊断中的应用、评估装置
CN116809027B (zh) * 2023-05-18 2026-01-27 复旦大学附属中山医院 一种用于捕获外泌体的异质性复合材料及其制备方法和应用
CN116990498B (zh) * 2023-09-28 2024-08-09 山东大学齐鲁医院 血浆色氨酸代谢物在儿童偏头痛诊断中的应用
CN117590005A (zh) * 2024-01-15 2024-02-23 中国疾病预防控制中心环境与健康相关产品安全所 空气污染致抑郁的代谢标志物组合及其筛选方法和应用
WO2025163640A1 (en) * 2024-01-31 2025-08-07 Sheba Impact Ltd. Ai based clinical decision support system (cdss) for mental health
CN118566488B (zh) * 2024-04-10 2026-02-27 合肥歆智医疗器械有限公司 抑郁症检测用试剂组合、制造方法、检测系统及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009006338A1 (en) * 2007-06-29 2009-01-08 Quest Diagnostics Investments Incorporated Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314144A (en) * 1996-02-02 1999-04-29 Smithkline Beecham Corp Computerised identification of at risk patients diagnosed with depression
GB9826899D0 (en) * 1998-12-08 1999-01-27 Knoll Ag Methods to treat depression and other psychiatric disorders and assays for compounds
WO2004080312A1 (ja) 2003-03-14 2004-09-23 Seizaburo Arita うつ病の診断方法
PT1866650E (pt) 2005-04-06 2010-06-01 Univ Antwerp Marcadores neurodegenerativos para a depressão
JP2007024822A (ja) 2005-07-21 2007-02-01 Aska Pharmaceutical Co Ltd 男性の更年期又はうつ病の鑑別方法
GB0524609D0 (en) * 2005-12-02 2006-01-11 Univ Cambridge Tech Methods of monitoring and diagnosing psychotic disorders and of identifying biomarkers for psychotic disorders
US7606622B2 (en) 2006-01-24 2009-10-20 Cardiac Pacemakers, Inc. Method and device for detecting and treating depression
US20080281531A1 (en) 2007-03-15 2008-11-13 Kazuhito Rokutan Method for Diagnosing Depression
CN101338337B (zh) * 2007-07-04 2011-11-02 北京华安佛医药研究中心有限公司 多态性位点基因型预测抑郁症及药效的用途、方法和试剂盒
JP2009092550A (ja) 2007-10-10 2009-04-30 Japan Health Science Foundation うつ病またはうつ状態の同定方法
JP2009187521A (ja) 2008-01-08 2009-08-20 Yaskawa Electric Corp 位置指令作成方法及び位置指令作成装置
JP2009291029A (ja) 2008-05-30 2009-12-10 Yazaki Corp コルゲートチューブ配索部材

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009006338A1 (en) * 2007-06-29 2009-01-08 Quest Diagnostics Investments Incorporated Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder;Modica-Napolitano等;《BIOL PSYCHIATRY》;20040201;第55卷(第3期);摘要，116-117页 *

Also Published As

Publication number Publication date
US8951739B2 (en) 2015-02-10
JP2012211908A (ja) 2012-11-01
JP2014013257A (ja) 2014-01-23
CN102667485A (zh) 2012-09-12
JPWO2011019072A1 (ja) 2013-01-17
CN104777314B (zh) 2017-01-04
DK2466312T3 (da) 2020-01-13
EP2466312A4 (en) 2013-03-13
EP2466312A1 (en) 2012-06-20
JP5372213B2 (ja) 2013-12-18
US20120282592A1 (en) 2012-11-08
US20150126623A1 (en) 2015-05-07
CN104777314A (zh) 2015-07-15
US9442121B2 (en) 2016-09-13
WO2011019072A1 (ja) 2011-02-17
EP2466312B1 (en) 2019-10-16
JP5859502B2 (ja) 2016-02-10

Similar Documents

Publication Publication Date Title
CN102667485B (zh) 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质
JP6927212B2 (ja) 軽度認知障害又はアルツハイマー型認知症の評価方法
US20150141528A1 (en) Neural specific s100b for biomarker assays and devices for detection of a neurological condition
EP3028049B1 (en) Diagnostic tools for alzheimer's disease
US20180275144A1 (en) Diagnostic tools for alzheimer's disease
JP6870679B2 (ja) アルツハイマー型認知症の将来の発症リスクの評価方法
EP3422008A1 (en) Novel biomarkers for cognitive impairment and methods for detecting cognitive impairment using such biomarkers
Siddique et al. Estimation of alpha-synuclein monomer and oligomer levels in the saliva of the children with autism spectrum disorder: a possibility for an early diagnosis
WO2022181333A1 (ja) 軽度認知障害検査
WO2018117064A1 (ja) うつ状態を呈する疾患を検査する方法
WO2013080917A1 (ja) 統合失調症の客観的評価法
JP7226732B2 (ja) 尿中腫瘍マーカーによるがん検出方法、キット及び装置
JP2024029191A (ja) 認知症又はそのリスクの検査方法
JP6222629B2 (ja) 排尿障害のバイオマーカー
CN105807067A (zh) 一种检测阿尔兹海默综合症ncam2的干式免疫荧光试剂盒和制备方法
RU2835349C1 (ru) Способ дифференциальной диагностики болезни Паркинсона и болезни диффузных телец Леви
GB2636339A (en) Biomarkers for bipolar disorder
KR20260006588A (ko) 경도인지장애 및 알츠하이머병에 대한 단백질 마커
WO2025024817A1 (en) Compositions, methods and uses for exosome-associated biomarkers for early diagnosis and treatment of health conditions
Yaplito-Lee et al. Correlation between dried blood spot thin layer chromatography and plasma high performance liquid chromatography of leucine/isoleucine levels among Filipino patients with maple syrup urine disease (MSUD) seen at the Institute of Human Genetics, National Institutes of Health

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant